“An Mrna Vaccine Against Sars-Cov-2 - Preliminary Report.”. N Engl J Med. N Engl J Med. doi:10.1056/NEJMoa2022483.
. 2020. “Safety And Immunogenicity Of Sars-Cov-2 Mrna-1273 Vaccine In Older Adults.”. N Engl J Med. N Engl J Med. doi:10.1056/NEJMoa2028436. https://pubmed.ncbi.nlm.nih.gov/32991794/.
. 2020. “Phase Ib Trial To Evaluate The Safety And Pharmacokinetics Of Multiple Ascending Doses Of Filociclovir (Mbx-400, Cyclopropavir) In Healthy Volunteers.”. Antimicrob Agents Chemother 63 (9). Antimicrob Agents Chemother. doi:10.1128/AAC.00717-19.
. 2019. “Safety And Immunogenicity Of A Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine In Healthy Persons ≥18 Years Old.”. J Infect Dis 212 (4). J Infect Dis: 552-61. doi:10.1093/infdis/jiv056.
. 2015.